---
title: "LUCIS PHARMA LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53
json: https://whiteintel.dev/api/public/dossier/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53
identifier: oo:GB-COH-08307830
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LUCIS PHARMA LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-08307830`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53  

## Ownership & control

### Owners / controllers

- **Mrs Kathryn Louise Diston-Hunter** (beneficial owner) — 75% — https://whiteintel.dev/entity/8d699d04-5e41-5904-a4d0-189b08636489
- **LUCIS HOLDINGS LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/332c556d-fd43-5ee6-8593-939c2dc143d5
- **Mrs Kathryn Louise Diston-Hunter** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/9bc45b33-c42c-4f53-9bc6-e812d41509f0
- **LUCIS HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/332c556d-fd43-5ee6-8593-939c2dc143d5
- **ROSEMONT PHARMACEUTICALS LIMITED** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/5f0b62fb-7162-59f0-b1b8-52943f25b8f7

### UBO chain (walk to the ultimate owner)

A **30-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `08307830`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2012-11-26
- **Registered office:** Rosemont House Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, England
- **SIC:** 46460

### Officers

- FAWCETT, Iain — director · British · appointed 2023-06-14
- WOOD, Gavin — director · British · appointed 2025-12-17
- DISTON-HUNTER, Kathryn Louise — secretary · appointed 2012-11-26 · resigned 2023-06-14
- BUSBY, Timothy Mark — director · British · appointed 2023-06-14 · resigned 2026-01-21
- DISTON-HUNTER, Kathryn Louise — director · British · appointed 2012-11-26 · resigned 2023-06-14
- DISTON-HUNTER, Stuart — director · British · appointed 2013-08-01 · resigned 2023-06-14
- TAYLOR, Howard Langton — director · British · appointed 2023-06-14 · resigned 2025-07-23

### Beneficial owners (Persons with Significant Control)

- [Lucis Holdings Limited](https://whiteintel.dev/entity/332c556d-fd43-5ee6-8593-939c2dc143d5) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06
- [Rosemont Pharmaceuticals Limited](https://whiteintel.dev/entity/5f0b62fb-7162-59f0-b1b8-52943f25b8f7) — 50–75% shares · corporate PSC · England — ceased 2025-11-19
- Mrs Kathryn Louise Diston-Hunter — 50–75% shares · individual PSC · United Kingdom — ceased 2023-06-14

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08307830
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08307830

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **LUCIS PHARMA LTD** — https://whiteintel.dev/entity/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LUCIS PHARMA LTD**. Human view: https://whiteintel.dev/entity/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53 · Structured JSON: https://whiteintel.dev/api/public/dossier/9ecbb7c3-dbe7-5bf5-a460-aa12f9a9ec53._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._